Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.9317Source: DataRank Database

Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 0. It has been cited 247 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access247 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (20)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Yang Yang ORCID,Ira M. Longini ORCID,M. Elizabeth Halloran ORCID,Natalie E. Dean ORCID,Zachary J. Madewell ORCID

Live enrichment

PubMed:35482308

National Institutes of Health

Grant: 5R01AI139761-05

Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats

NIAID NIH HHS

Grant: R01 AI139761

goldLicense: cc-by

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2791601/madewell_2022_oi_220282_1650462141.35109.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9051991

https://doi.org/10.1001/jamanetworkopen.2022.9317

https://doi.org/10.1101/2022.01.09.22268984

https://www.medrxiv.org/content/medrxiv/early/2022/01/11/2022.01.09.22268984.full.pdf

Fields of Study

0303 health sciences03 medical and health sciencesCOVID-19HumansIncidenceSARS-CoV-2VaccinationSARS-CoV-2 variants

MeSH Terms

COVID-19HumansIncidenceSARS-CoV-2Vaccination

Keywords

SARS-CoV-2IncidenceVaccinationCOVID-19HumansArticleOriginal Investigation

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation: results from a case–control study

10.6084/m9.figshare.23583522.v1figshare

Additional file 1 of Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation: results from a case–control study

10.6084/m9.figshare.23583522figshare

Additional file 1 of Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants

10.6084/m9.figshare.23583615.v1figshare

Additional file 1 of Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants

10.6084/m9.figshare.23583615figshare

Additional file 1 of Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022

10.6084/m9.figshare.25107764.v1figshare

Additional file 1 of Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022

10.6084/m9.figshare.25107764figshare

Additional file 1 of How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022

10.6084/m9.figshare.25980533.v1figshare

Additional file 1 of How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022

10.6084/m9.figshare.25980533figshare